Biostatistician Margaret Gamalo says innovation in statistics and regulatory science involves incremental progress, requires the engagement of various stakeholders, and often unfolds in a nonlinear manner.
Center for Drug Evaluation and Research
Registration Open for Symposium on AI in Pharmaceutical Medicine
The symposium, which can be attended in person or virtually, will take place June 10–11 at the Northeastern University campus in Boston with the theme Generative AI in Medical Research and Drug Development: Hype or Reality?
Practical Significance | Episode 25: Meet the New ASA President, Dionne Price
Practical Significance kicks off the new year with its January tradition of featuring the new ASA president. Co-hosts Donna and Ron welcome to the show Dionne Price, the 118th president of the American Statistical Association. Dionne—who is the deputy director of the Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, […]
Obituaries for March 2022
ASA members L. Adrienne Cupples, Peter “Tony” Lachenbruch, and Kooros Mahjoob-Behrooz passed away recently.
Meet Sylva Collins, Director of the Office of Biostatistics, US Food and Drug Administration
Sylva Collins joined the FDA’s Office of Biostatistics in 2019 and has more than 30 years of drug development experience and biostatistics leadership.